SLENYTO® (melatonin extended-release tablets) is now available in Canada as a prescription treatment for insomnia in children and adolescents with autism spectrum disorder ...

Kye Pharmaceuticals, Inc. ("Kye") announced today that SLENYTO® (melatonin extended-release tablets) is now available across Canada. SLENYTO® is approved as a prescription medicine in Canada for the ...

Restoring inhibitory neuron plasticity may reverse neurodevelopmental disorder symptoms, preclinical study suggests

Some of the symptoms of neurodevelopmental disorders (NDDs), such as autism spectrum disorder and epilepsy, may result from ...
The American Journal of Managed Care

Stiff Person Syndrome Spectrum Disorders: Knowledge Gaps and Future Research Considerations

Although rare, stiff person syndrome spectrum disorders can significantly affect patient quality of life, and current knowledge gaps warrant further research. A recent review provides updates on the ...
Neuroscience NewsOpinion

Autism Spectrum May Be Too Broad

A new study argues argues the autism spectrum has become an overly broad catch-all, risking overdiagnosis and calling for ...

Beyond Behçet’s Disease: A New Genetic Framework Helps Decode Pediatric Inflammatory Disorders

Now, researchers have formalized a concept that may help solve it: Behçet’s spectrum disorders (BSD). First introduced in 2020, the BSD framework pulls together a diverse set of inflammatory ...

Adults with fetal alcohol spectrum disorder help illuminate a dire need for effective housing

Canadian adults with fetal alcohol spectrum disorder (FASD) experience compounding barriers to housing because of a systemic ...